- Home
- GENK vs SCNX Comparison
GENK vs SCNX Comparison
Compare GENK & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- SCNX
- Stock Information
- Founded
- GENK 2011
- SCNX 2010
- Country
- GENK United States
- SCNX United States
- Employees
- GENK N/A
- SCNX N/A
- Industry
- GENK Restaurants
- SCNX Other Pharmaceuticals
- Sector
- GENK Consumer Discretionary
- SCNX Health Care
- Exchange
- GENK Nasdaq
- SCNX Nasdaq
- Market Cap
- GENK 20.4M
- SCNX 14.4M
- IPO Year
- GENK 2023
- SCNX 2020
- Fundamental
- Price
- GENK $3.89
- SCNX $1.60
- Analyst Decision
- GENK Strong Buy
- SCNX
- Analyst Count
- GENK 2
- SCNX 0
- Target Price
- GENK $10.00
- SCNX N/A
- AVG Volume (30 Days)
- GENK 57.3K
- SCNX 176.5K
- Earning Date
- GENK 07-30-2025
- SCNX 08-10-2025
- Dividend Yield
- GENK 0.77%
- SCNX N/A
- EPS Growth
- GENK N/A
- SCNX N/A
- EPS
- GENK N/A
- SCNX N/A
- Revenue
- GENK $214,957,000.00
- SCNX $146,901.00
- Revenue This Year
- GENK $16.62
- SCNX N/A
- Revenue Next Year
- GENK $20.40
- SCNX N/A
- P/E Ratio
- GENK N/A
- SCNX N/A
- Revenue Growth
- GENK 14.40
- SCNX N/A
- 52 Week Low
- GENK $3.16
- SCNX $0.69
- 52 Week High
- GENK $10.33
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- GENK 49.63
- SCNX N/A
- Support Level
- GENK $3.72
- SCNX N/A
- Resistance Level
- GENK $3.98
- SCNX N/A
- Average True Range (ATR)
- GENK 0.22
- SCNX 0.00
- MACD
- GENK 0.02
- SCNX 0.00
- Stochastic Oscillator
- GENK 59.46
- SCNX 0.00
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.